• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经肠外途径获得的慢性丙型肝炎患者发生肝硬化的预测因素:免疫功能正常与免疫功能低下患者的比较

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

作者信息

Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B

机构信息

Unité d' Hépatologie, Hôpital Necker, Paris, France.

出版信息

J Hepatol. 1998 Jul;29(1):12-9. doi: 10.1016/s0168-8278(98)80173-6.

DOI:10.1016/s0168-8278(98)80173-6
PMID:9696487
Abstract

BACKGROUND/AIMS: The aim of this study was to evaluate the impact of the host immune status and of virological and environmental parameters on the development of cirrhosis during chronic hepatitis C virus infection.

METHODS

Liver histology (cirrhosis or not, Knodell score) was evaluated according to age, sex, route and age of contamination, alcohol consumption and immune status in a large series of 553 HBsAg-negative patients (whose duration of hepatitis C virus infection could be precisely evaluated) divided into three groups: group 1 consisted of 462 immunocompetent subjects (46.1% intravenous drug users, 53.9% transfused), infected for a mean of 12.5+/-6.7 years, including 16.6% of alcohol abusers (>80 g/day); groups 2a and 2b consisted of 91 immunocompromised patients, 52 human immunodeficiency virus-coinfected patients corresponding to group 2a and 39 kidney recipients undergoing immunosuppressive therapy for group 2b, having been infected by hepatitis C virus for a mean of 12.6+/-5.3 and 11.5+/-5.3 years, respectively.

RESULTS

Group 1: cirrhosis was present in 11.0% of group 1 patients and in 23.6% of immunocompetent patients with a duration of hepatitis C virus infection of 20 years or more. Forty-three percent of patients with cirrhosis and with hepatitis C virus infection for more than 20 years were alcohol abusers. The time taken to develop cirrhosis was 14+/-7 years in patients infected before the age of 40 years as compared to 8+/-5 years in those infected after 40 years (p<0.001). Groups 2a and 2b: cirrhosis was present in 19.8% of immunocompromised patients, a significantly higher rate than in immunocompetent patients (p<0.01). Alcohol abuse did not increase the risk of cirrhosis in this group. All patients but one were infected by hepatitis C virus before the age of 40 and the calculated time elapsed until the occurrence of cirrhosis was 12.4+/-5.5 years. In groups 1, 2a and 2b, there was no relation between histological severity, hepatitis C virus genotype and viral load. Four variables were independently associated with the occurrence of cirrhosis in the multivariate analysis: age over 40 at time of contamination (RR=9.3 in age range 40 to 59 and 91.2 in > or =60 years); long duration (> or =20 years) of hepatitis C virus infection (RR=15.4); alcohol consumption over 80 g/d (RR=2.9); and human immunodeficiency virus-coinfection (RR=2.6).

CONCLUSIONS

Our study on a large series of well-characterized patients provides an accurate evaluation of the risk of cirrhosis in parenterally-contaminated immunocompetent hepatitis C virus-infected patients, with an overall figure of 11%. It also demonstrates the impact of the host immune status on the risk of severe histological lesions during chronic hepatitis C virus infection. It finally establishes the importance of age at the time of viral infection in the occurrence of cirrhosis, as well as the importance of alcohol consumption. Thus, at least following parenteral infection, both host-related and environmental cofactors play a major role in the severity of the liver lesions associated with hepatitis C virus infection.

摘要

背景/目的:本研究旨在评估宿主免疫状态、病毒学和环境参数对慢性丙型肝炎病毒感染期间肝硬化发展的影响。

方法

根据年龄、性别、感染途径和年龄、饮酒情况及免疫状态,对553例HBsAg阴性患者(其丙型肝炎病毒感染持续时间可精确评估)进行肝组织学评估(有无肝硬化、Knodell评分),这些患者分为三组:第1组由462例免疫功能正常的受试者组成(46.1%为静脉吸毒者,53.9%为输血感染者),平均感染12.5±6.7年,其中16.6%为酗酒者(>80克/天);第2a组和第2b组由91例免疫功能低下患者组成,第2a组为52例合并人类免疫缺陷病毒感染的患者,第2b组为39例接受免疫抑制治疗的肾移植受者,分别平均感染丙型肝炎病毒12.6±5.3年和11.5±5.3年。

结果

第1组:第1组患者中11.0%存在肝硬化,丙型肝炎病毒感染持续20年或更长时间的免疫功能正常患者中23.6%存在肝硬化。丙型肝炎病毒感染超过20年的肝硬化患者中43%为酗酒者。40岁之前感染的患者发展为肝硬化的时间为14±7年,而40岁之后感染的患者为8±5年(p<0.001)。第2a组和第2b组:免疫功能低下患者中19.8%存在肝硬化,这一比例显著高于免疫功能正常患者(p<0.01)。酗酒并未增加该组肝硬化的风险。除1例患者外,所有患者均在40岁之前感染丙型肝炎病毒,计算至肝硬化发生的时间为12.4±5.5年。在第1组、第2a组和第2b组中,组织学严重程度、丙型肝炎病毒基因型和病毒载量之间无关联。多变量分析显示,四个变量与肝硬化的发生独立相关:感染时年龄超过40岁(40至59岁年龄组RR=9.3,≥60岁年龄组RR=91.2);丙型肝炎病毒感染持续时间长(≥20年)(RR=15.4);饮酒量超过80克/天(RR=2.9);合并人类免疫缺陷病毒感染(RR=2.6)。

结论

我们对大量特征明确的患者进行的研究准确评估了经肠道外感染的免疫功能正常的丙型肝炎病毒感染患者发生肝硬化的风险,总体风险为11%。该研究还证明了宿主免疫状态对慢性丙型肝炎病毒感染期间严重组织学病变风险的影响。最终确立了病毒感染时的年龄在肝硬化发生中的重要性以及饮酒的重要性。因此,至少在肠道外感染后,宿主相关和环境共同因素在丙型肝炎病毒感染相关肝损伤的严重程度中起主要作用。

相似文献

1
Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.经肠外途径获得的慢性丙型肝炎患者发生肝硬化的预测因素:免疫功能正常与免疫功能低下患者的比较
J Hepatol. 1998 Jul;29(1):12-9. doi: 10.1016/s0168-8278(98)80173-6.
2
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.人类免疫缺陷病毒合并感染对注射吸毒者慢性丙型肝炎的影响:一项长期回顾性队列研究。
Hepatology. 2001 Dec;34(6):1193-9. doi: 10.1053/jhep.2001.29201.
3
Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.丙型肝炎病毒持续时间和丙型肝炎病毒基因型对肾移植患者的影响:与临床病理特征的相关性
Transplantation. 1998 Apr 15;65(7):930-6. doi: 10.1097/00007890-199804150-00012.
4
[Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].[波兰慢性丙型肝炎患者的肝纤维化进展率]
Pol Arch Med Wewn. 2003 Aug;110(2):869-75.
5
[Clinical forms and prognosis of hepatitis C].[丙型肝炎的临床类型与预后]
Rev Prat. 2000 May 15;50(10):1083-8.
6
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.慢性丙型肝炎患者肝纤维化进展的自然史。OBSVIRC、METAVIR、CLINIVIR和DOSVIRC组。
Lancet. 1997 Mar 22;349(9055):825-32. doi: 10.1016/s0140-6736(96)07642-8.
7
Histological features of chronic hepatitis C in haemodialysis patients.血液透析患者慢性丙型肝炎的组织学特征。
Liver Int. 2014 Jul;34(6):e56-61. doi: 10.1111/liv.12413. Epub 2013 Dec 17.
8
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.普通人群中丙型肝炎病毒相关肝病的临床病程及危险因素:狄俄尼索斯研究报告
Gut. 1999 Jun;44(6):874-80. doi: 10.1136/gut.44.6.874.
9
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
Hepatology. 1997 Sep;26(3):776-9. doi: 10.1002/hep.510260334.
10
Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.爱尔兰受污染抗-D 免疫球蛋白感染丙型肝炎的女性队列中的疾病结局。
J Hepatol. 2017 Dec;67(6):1140-1147. doi: 10.1016/j.jhep.2017.07.034. Epub 2017 Aug 24.

引用本文的文献

1
Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study.丙型肝炎相关严重肝脏疾病和患者风险因素的地理差异:一项多中心横断面研究。
Epidemiol Infect. 2023 Mar 14;151:e59. doi: 10.1017/S0950268823000377.
2
Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study.2007 年至 2017 年韩国丙型肝炎病毒感染的流行病学和临床特征:一项前瞻性多中心队列研究。
Gut Liver. 2020 Mar 15;14(2):207-217. doi: 10.5009/gnl19005.
3
Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.
在 CD4 细胞计数低于 200 个/立方毫米的丙型肝炎感染吸毒者中,女性的临床肝脏疾病进展比男性更为明显。
Open Forum Infect Dis. 2015 Dec 31;3(1):ofv214. doi: 10.1093/ofid/ofv214. eCollection 2016 Jan.
4
Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China.中国云南省丙型肝炎病毒单一感染及HCV/HIV合并感染个体的血浆丙型肝炎病毒载量
Hepat Mon. 2012 Jul;12(7):453-9. doi: 10.5812/hepatmon.6160. Epub 2012 Jul 30.
5
Underlying pathophysiology of HCV infection in HIV-positive drug users.HIV 阳性吸毒者丙型肝炎病毒感染的潜在病理生理学
J Addict Dis. 2008;27(2):75-82. doi: 10.1300/J069v27n02_09.
6
Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.对影响丙型肝炎进展的遗传因素的认识:个性化治疗的潜力。
Mol Diagn Ther. 2008;12(4):209-18. doi: 10.1007/BF03256286.
7
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.人类免疫缺陷病毒(HIV)感染对丙型肝炎病毒感染患者肝纤维化进展的影响。
Gut. 2003 Jul;52(7):1035-40. doi: 10.1136/gut.52.7.1035.
8
Hepatitis C and HIV-1 coinfection.丙型肝炎与人类免疫缺陷病毒1型合并感染。
Gut. 2002 Oct;51(4):601-8. doi: 10.1136/gut.51.4.601.
9
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.血清丙型肝炎病毒RNA水平与肝脏组织学损伤相关,且在慢性丙型肝炎进展过程中与脂肪变性同时出现。
Dig Dis Sci. 2001 Aug;46(8):1677-83. doi: 10.1023/a:1010697319589.